glp 1 agonist or antagonist GLP-1 Agonists - What is it? Comparing Ozempic, Wegovy and Other

Are those industries at risk right now and, if not, when

Retatrutide: A Triple Agonist with Unprecedented Efficacy Retatrutide (LY3437943) is a novel triple incretin agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

Drummond, R

Common side effects are injection site reactions, nausea, abdominal discomfort, flu-like symptoms, and skin hyperpigmentation [48]

Its pen required reconstitution (the drug came as powder to mix) similar to early Bydureon

In the safety profile, pooling three studies with 640 patients, most adverse events associated with retatrutide were mild and did not result in treatment discontinuation